1 / 13

HCV HIV

HCV HIV. Kees Brinkman afd Interne Geneeskunde. Virale Hepatitis ( = geelzucht). leverontsteking veroorzaakt door virus “5” soorten: hepatitis A via “ poep” hepatitis B via bloed / naalden / M-K / sex

bunny
Download Presentation

HCV HIV

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HCV HIV Kees Brinkman afd Interne Geneeskunde

  2. Virale Hepatitis ( = geelzucht) leverontsteking veroorzaakt door virus “5” soorten: • hepatitis A via “ poep” • hepatitis B via bloed / naalden / M-K / sex • hepatitis C via bloed / naalden / (M-K) niet per se via sex! • hepatitis D alleen samen met HBV • hepatitis E via “poep” (Azië)

  3. Virale Hepatitisgenezing? • hepatitis A spontaan 99,9 % • hepatitis B spontaan 95% 5% chronisch • hepatitis C spontaan 20-30% 70 - 80% chronisch • hepatitis E spontaan 99,9 % chronische hepatitis B/C: besmettelijk voor anderen

  4. Chronische Hepatitis→ cirrose • duur: 15 – 60 jaar • alcohol !! • therapie: levertransplantatie • extra risico: leverkanker

  5. HCV & HIV • bekende associatie • chronische HIV & chronische HCV • risicogroepen: • (ex) IVDU • bloedtransfusies • hemofilie e.d. NB geen duidelijke sexuele overdracht bekend

  6. Prevalence of HCV and HBV Co-infection in persons living with HIV EuroSIDA cohort • Among 9803 subjects in the EuroSIDA Cohort: • of 5883 HBsAgtest available attime of enrollment • 530 (9%) positive • of 5957 HCVAb test available • 1960 (33%) positive HBV:9.7% Argentina HBV+: 7.8% North: HCV+ 24,5 % HBV 6% HBV 9.2% East: HCV+ 47,7 % Central: HCV+22,9 % HBV+ 9.1% Konopnicki D et al.; AIDS. 2005. Rockstroh J et al.; JID 2005 South: HCV+ 44,9 %

  7. HCV bij HIVin Nederland SHM 2005: • 9088 patienten • 839 HCV positief (10,6%) • IVDU: 94,4% • heterosex: 5,1 % • MSM: 3,0%

  8. Natural history of HCV infection in HIV+: HCV infection HIV  Resolved 10% Chronic Infection 90% Normal ALT 55% Mild disease Elevated ALT 45% HIV  Cirrhosis 25% HIV  HCC Liver failure Liver Related Mortality HIV 

  9. Incidence of HCV-related cirrhosis in HIV-infected patients Ten-Year Incidence Mean Time to of Cirrhosis Cirrhosis 23.2 20 25 14.9 20 15 P<0.001 15 P<0.01 Frequency (%) Time (years) 10 10 6.9 2.6 5 5 0 0 HCV HIV/HCV HCV HIV/HCV Soto et al. J Hepatol 1997;26:1-5

  10. The effect of HIV coinfection on the risk of cirrhosis and HCC in US veterans with HCV • 26,641 patients with HCV only and 4761 with HCV/HIV coinfection • An increased risk of cirrhosis and HCC in patients with coinfection was only found during the pre-HAART-era (before 10/1996) (hazard ratio 1.48, 1.06-2.07, p=0.02) but not among patients who entered the cohort during the HAART era Kramer JR et al., Am J Gastroenterol 2005

  11. Impact of ART on Overall Liver Mortalityin HIV/HCV-Coinfected Patients Overall Mortality • Bonn cohort (1990-2002) • 285 HIV/HCV coinfected patients • Liver-related mortality rates per 100 person-years • HAART: 0.45 • ART: 0.69 • No therapy: 1.70 • Predictors for liver-related mortality • No HAART • Low CD4 cell count • Increasing age HAART* Cumulative Survival ART No therapy *P<0.001 0 1000 2000 3000 4000 5000 6000 Days Liver-Related Mortality HAART* ART No therapy Cumulative Survival *P=0.018 0 1000 2000 3000 4000 5000 6000 Days Qurishi N, et al. Lancet. 2003:362:1708-1713.

  12. acute HCV bij HIV hoe ontdekt: - bij alle HIV patiënten: controle leverwaarden - bij stijging: onderzoek naar hepatitis NB: weinig kennis over acute HCV !

More Related